Latest R. Scott Turner Stories

Alzheimer's Disease May One Day Be Diagnosed By Visual Cues
2013-11-13 14:25:05

[ Watch the Video: Vision Loss Linked With Alzheimer’s Disease ] Susan Bowen for redOrbit.com - Your Universe Online In the future, your optometrist may be the first person to realize that you could have Alzheimer’s disease (AD). An international team of researchers has discovered the loss of a particular layer of retinal cells may reveal the presence of the disease. Led by R.C. Chang from the University of Hong Kong, along with researchers from Georgetown University Medical...

2013-07-15 13:06:07

When Georgetown University neurologist R. Scott Turner, MD, PhD, began enrolling people with mild to moderate Alzheimer's disease into a nationwide study last year, he expected to find only a handful of participants with undiagnosed glucose intolerance, as all the patients were already under a doctor's care and those with known diabetes were excluded. But Turner says he was "shocked" by how many study participants were found to have pre-diabetes — a finding that is...

2012-05-14 09:57:39

Could a compound found in red wine and red grapes change the course of the illness? A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study....

2011-11-14 23:24:26

Georgetown researchers say therapy may work best in patients with early disease when amyloid burden is lower Patients with Alzheimer's disease who are in the early stages of their illness will likely benefit most from vaccine therapies now being tested in a number of human clinical trials, say researchers from Georgetown University Medical Center (GUMC). Their study, presented at the annual meeting of the Society for Neuroscience, Neuroscience 2011, is the first to show that mice with a...

2009-09-22 13:58:41

Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial "“ the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease. The phase II study examines the safety and possible benefits of CERE-110. CERE-110 contains a gene and is injected during surgery into a part of the brain affected by Alzheimer's disease. The gene will instruct brain cells to produce more...

Word of the Day
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.